26 januari 2006: Bron: Gynecol Oncol. 2006 Jan 19:

Palliatieve bestraling bij patiënten met een of meerdere keren een recidief van eierstokkanker met klachten als pijn en bloedingen is significant effectief blijkt uit een studie uitgevoerd in Canada. Of hierbij ook hyperthermie als aanvullende behandeling is gebruikt blijkt niet uit deze studie, maar is dus ook nog een tip om naast een eventuele bestraling ook hyperthermie te gebruiken.

Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer.

E C, Quon M, Gallant V, Samant R.
Division of Radiation Oncology, The Ottawa Hospital Regional Cancer Centre, The Ottawa Hospital, 501 Smyth Road, Ottawa, Canada ON K1H 8L6; The Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada; University of Ottawa, Ottawa, Ontario, Canada.

OBJECTIVE.: To evaluate the efficacy of radiotherapy (RT) for symptomatic recurrent or residual ovarian cancer.

METHODS.: A review was conducted on patients (pts) treated with palliative RT for symptomatic ovarian cancer at The Ottawa Hospital Regional Cancer Centre between 1990 and 2003. Patient demographics, tumor factors, treatment variables, and clinical outcome were entered into a database. Symptom response was defined as complete (CR), partial (PR), or none.

RESULTS.: 62 courses of RT were delivered to 53 pts. The symptoms treated were: bleeding (40%), pain (37%), and 'others' (23%). The most common dose fractionation scheme was 30 Gy in 10 fractions (f) (range: 5 Gy/1 f to 52.5 Gy/20 f). The overall response rate was 100%, with 68% achieving a CR. The CR rates were 88, 65, and 36% for the symptoms of bleeding, pain, and 'others', respectively (P = 0.003). The median duration of response was 4.8 months (range: 1-71 months). In multivariate analysis, the only factors that were found to be significant positive predictors of symptom control were: the symptom bleeding (P = 0.015) and stage III/IV disease at presentation (P = 0.01). The most commonly reported toxicities were grades 1 and 2 nausea/vomiting and diarrhea. There were no grade 3/4 toxicities reported.

CONCLUSIONS.: Radiotherapy is highly effective in palliating symptomatic ovarian cancer. Excellent results are achieved for patients presenting with bleeding or pain. Symptomatic patients should be strongly considered for palliative radiotherapy. Higher doses of radiotherapy should be considered for those with symptoms other than bleeding or pain and those with longer life expectancies.

PMID: 16427685 [PubMed - as supplied by publisher]

Plaats een reactie ...

Reageer op "Bestraling: Palliatieve bestraling bij patiënten met meerdere keren een recidief van eierstokkanker en veel pijn en bloedingen is significant effectief."


Gerelateerde artikelen
 

Gerelateerde artikelen

ESMO 2023: aanbevolen abstracten >> ASCO 2023: aanbevolen abstracten >> Podcast gesprekken in het >> Algemeen: voor vrouwen met >> Avastin - bevacizumab naast >> Bestraling: Palliatieve bestraling >> PARP remmers zoals olaparib, >> Chemo bij eierstokkanker: >> Diagnose technieken bij eierstokkanker: >> Hormoontherapie stoppen in >>